REGγ 3 is critical for skin carcinogenesis by modulating the Wnt/β 2-catenin pathway

Nature Communications

Volumn 6, Issue , 2015, Pages

  Li, Lei ^a,b   Dang, Yongyan ^b   Zhang, Jishen ^a   Yan, Wangjun ^a   Zhai, Wanli ^b   Chen, Hui ^b   Li, Ke ^b   Tong, Lu ^b   Gao, Xiao ^b   Amjad, Ali ^b   Ji, Lei ^b   Jing, Tiantian ^b   Jiang, Ziwei ^b   Shi, Kaixuan ^b   Yao, Liangfang ^b   Song, Dianwen ^a   Liu, Tielong ^a   Yang, Xinghai ^a   Yang, Cheng ^a   Cai, Xiaopan ^a   Xu, Wei ^a   Huang, Quan ^a   He, Jin ^a   Liu, Jian ^c   Chen, Tenghui ^d   Moses, Robb E ^c   Fu, Junjiang ^e   Xiao, Jianru ^a   Li, Xiaotao ^c   more..

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b EAST CHINA NORMAL UNIVERSITY   (China)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE P38; MYC PROTEIN; PEPTIDES AND PROTEINS; PHORBOL 13 ACETATE 12 MYRISTATE; REG GAMMA; UNCLASSIFIED DRUG; WNT PROTEIN; AUTOANTIGEN; CARCINOGEN; CCND1 PROTEIN, MOUSE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; KI ANTIGEN; MYC PROTEIN, MOUSE; PROTEASOME; TRANSCRIPTION FACTOR AP 1;

CANCER; CARCINOGEN; ENZYME ACTIVITY; PROTEIN; SIGNALING; SKIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; EPIDERMIS HYPERPLASIA; FEMALE; GENE DELETION; IN VITRO STUDY; KERATINOCYTE; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; SKIN PAPILLOMA; UPREGULATION; WNT SIGNALING PATHWAY; ANIMAL; ANTAGONISTS AND INHIBITORS; CARCINOGENESIS; CELL LINE; CHEMICALLY INDUCED; CYTOLOGY; DRUG EFFECTS; GENE SILENCING; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; SKIN TUMOR;

MUS;

ANIMALS; AUTOANTIGENS; CARCINOGENESIS; CARCINOGENS; CELL LINE; CELL PROLIFERATION; CYCLIN D1; GENE KNOCKDOWN TECHNIQUES; GLYCOGEN SYNTHASE KINASE 3; HUMANS; KERATINOCYTES; MICE; MICE, KNOCKOUT; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-MYC; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1; WNT SIGNALING PATHWAY;

EID: 84928812853     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7875     Document Type: Article

References (44)

1. Li, X. et al. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATPindependent manner by the REGgamma proteasome. Cell 124, 381-392 (2006).
2. Li, X. et al. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway. Mol. Cell 26, 831-842 (2007).
3. Chen, X., Barton, L. F., Chi, Y., Clurman, B. E. & Roberts, J. M. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. Mol. Cell 26, 843-852 (2007).
4. Okamura, T. et al. Abnormally high expression of proteasome activator-gamma in thyroid neoplasm. J. Clin. Endocrinol. Metab. 88, 1374-1383 (2003).
5. Wang, X. et al. REG gamma: a potential marker in breast cancer and effect on cell cycle and proliferation of breast cancer cell. Med. Oncol. 28, 31-41 (2011).
6. Roessler, M. et al. Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis. Mol. Cell Proteomics 5, 2092-2101 (2006).
7. Truman, J. P. et al. PKCalpha activation downregulates ATM and radiosensitizes androgen-sensitive human prostate cancer cells in vitro and in vivo. Cancer Biol. Ther. 8, 54-63 (2009).
8. Breitkreutz, D., Braiman-Wiksman, L., Daum, N., Denning, M. F. & Tennenbaum, T. Protein kinase C family: on the crossroads of cell signaling in skin and tumor epithelium. J. Cancer Res. Clin. Oncol. 133, 793-808 (2007).
9. Denning, M. F. Protein kinase C/mitogen-activated protein kinase signaling in keratinocyte differentiation control. J. Invest. Dermatol. 130, 1968-1970 (2010).
10. Dhillon, A. S., Hagan, S., Rath, O. & Kolch, W. MAP kinase signalling pathways in cancer. Oncogene 26, 3279-3290 (2007).
11. Dajee, M. et al. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421, 639-643 (2003).
12. Su, F. et al. RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors. N. Engl. J. Med. 366, 207-215 (2012).
13. Bhatia, N. & Spiegelman, V. S. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis. Mol. Carcinog. 42, 213-221 (2005).
14. Chan, E. F., Gat, U., McNiff, J. M. & Fuchs, E. A common human skin tumour is caused by activating mutations in beta-catenin. Nat. Genet. 21, 410-413 (1999).
15. Oskarsson, T. et al. Skin epidermis lacking the c-Myc gene is resistant to Ras-driven tumorigenesis but can reacquire sensitivity upon additional loss of the p21Cip1 gene. Genes Dev. 20, 2024-2029 (2006).
16. Wettenhall, J. M. & Smyth, G. K. limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics 20, 3705-3706 (2004).
17. Hirai, S. & Yaniv, M. Jun DNA-binding is modulated by mutations between the leucines or by direct interaction of fos with the TGACTCA sequence. New Biol. 1, 181-191 (1989).
18. Li, L. et al. REGgamma deficiency promotes premature aging via the casein kinase 1 pathway. Proc. Natl Acad. Sci. USA 110, 11005-11010 (2013).
19. Wang, Y. et al. Wnt/b-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. Cancer Res. 68, 4287-4295 (2008).
20. Sharma, A., Luke, C. T., Dower, N. A., Stone, J. C. & Lorenzo, P. S. RasGRP1 is essential for ras activation by the tumor promoter 12-O-tetradecanoylphorbol- 13-acetate in epidermal keratinocytes. J. Biol. Chem. 285, 15724-15730 (2010).
21. Min, D. S., Shin, E. Y. & Kim, E. G. The p38 mitogen-activated protein kinase is involved in stress-induced phospholipase D activation in vascular smooth muscle cells. Exp. Mol. Med. 34, 38-46 (2002).
22. Hsieh, Y. H. et al. p38 mitogen-activated protein kinase pathway is involved in protein kinase Calpha-regulated invasion in human hepatocellular carcinoma cells. Cancer Res. 67, 4320-4327 (2007).
23. Chun, K. S., Kim, S. H., Song, Y. S. & Surh, Y. J. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin. Carcinogenesis 25, 713-722 (2004).
24. Liu, K. et al. Sunlight UV-induced skin cancer relies upon activation of the p38alpha signaling pathway. Cancer Res. 73, 2181-2188 (2013).
25. Schindler, E. M. et al. p38delta Mitogen-activated protein kinase is essential for skin tumor development in mice. Cancer Res. 69, 4648-4655 (2009).
26. Chun, K. S. et al. Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signalregulated kinase activity and NF-kappaB activation. Carcinogenesis 24, 1515-1524 (2003).
27. O'Kane, C. M. et al. STAT3, p38 MAPK, and NF-kappaB drive unopposed monocyte-dependent fibroblast MMP-1 secretion in tuberculosis. Am. J. Respir. Cell Mol. Biol. 43, 465-474 (2010).
28. Chen, J. R. et al. Dietary-induced serum phenolic acids promote bone growth via p38 MAPK/beta-catenin canonical Wnt signaling. J. Bone Miner. Res. 25, 2399-2411 (2010).
29. Jeong, A. Y., Lee, M. Y., Lee, S. H., Park, J. H. & Han, H. J. PPARdelta agonistmediated ROS stimulates mouse embryonic stem cell proliferation through cooperation of p38 MAPK and Wnt/beta-catenin. Cell Cycle 8, 611-619 (2009).
30. Wang, X. H. et al. Wnt/beta-catenin signaling regulates MAPK and Akt1 expression and growth of hepatocellular carcinoma cells. Neoplasma 58, 239-244 (2011).
31. Luna-Ulloa, L. B., Hernandez-Maqueda, J. G., Castaneda-Patlan, M. C. & Robles-Flores, M. Protein kinase C in Wnt signaling: implications in cancer initiation and progression. IUBMB Life 63, 915-921 (2011).
32. Hoesel, B. & Schmid, J. A. The complexity of NF-kappaB signaling in inflammation and cancer. Mol. Cancer 12, 86 (2013).
33. Arumugam, A. et al. Combined inhibition of p38 and Akt signaling pathways abrogates cyclosporine A-mediated pathogenesis of aggressive skin SCCs. Biochem. Biophys. Res. Commun. 425, 177-181 (2012).
34. Gao, C. et al. Induction of Gsk3beta-beta-TrCP interaction is required for late phase stabilization of beta-catenin in canonical Wnt signaling. J. Biol. Chem. 289, 7099-7108 (2014).
35. Zhang, M. et al. Smad3 prevents beta-catenin degradation and facilitates betacatenin nuclear translocation in chondrocytes. J. Biol. Chem. 285, 8703-8710 (2010).
36. Liu, J. et al. REGgamma modulates p53 activity by regulating its cellular localization. J. Cell Sci. 123, 4076-4084 (2010).
37. Weinberg, W. C. & Denning, M. F. P21Waf1 control of epithelial cell cycle and cell fate. Crit. Rev. Oral Biol. Med. 13, 453-464 (2002).
38. Barton, L. F. et al. Immune defects in 28-kDa proteasome activator gammadeficient mice. J. Immunol. 172, 3948-3954 (2004).
39. Furstenberger, G. & Kopp-Schneider, A. Malignant progression of papillomas induced by the initiation-promotion protocol in NMRI mouse skin. Carcinogenesis 16, 61-69 (1995).
40. Gebhardt, C. et al. RAGE signaling sustains inflammation and promotes tumor development. J. Exp. Med. 205, 275-285 (2008).
41. Leventaki, V. et al. NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma. Blood 10, 1621-1630 (2007).
42. Ban, K., Peng, Z., Lin, W. & Kozar, R. A. Arginine decreases peroxisome proliferator-activated receptor-gamma activity via cJun. Mol. Cell Biochem. 362, 7-13 (2012).
43. Bae, C. H., Kim, H. S., Song, S. Y. & Kim, Y. D. Phorbol 12-myristate 13-acetate induces MUC16 expression via PKCdelta and p38 in human airway epithelial cells. Clin. Exp. Otorhinolaryngol. 5, 161-169 (2012).
44. Ali, A. et al. Differential regulation of the REGgamma-proteasome pathway by p53/TGF-beta signalling and mutant p53 in cancer cells. Nat. Commun. 4, 2667 (2013).